BioPorto A/S
BIOPOR
Clasificación en acciones
#22955
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Precio por acción
$0.15400149
Última sincronización: 2026-10-21
Capitalización bursátil
$76.25M
Cambio (1 día)
-5.83%
Cambio (1 año)
-46.53%
País
DK
Comercio BioPorto A/S (BIOPOR)
Categoría
Healthcare
Historial del precio de la acción de BioPorto A/S (BIOPOR)
Precio más alto de cierre: $0.15 el 2026-10-01
Precio más bajo de cierre: $0.41 el 2019-12-01
Precio más bajo de cierre: $0.41 el 2019-12-01
Historial del precio de la acción de BioPorto A/S desde 2019 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -35.46% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $22.06 | 55.84% |
CN
|
|
| $177.93 | 21.98% |
US
|
